Standard BioTools Inc’s recently made public that its Former Officer Black Jeffrey G. acquired Company’s shares for reported $0.12 million on Nov 12 ’24. In the deal valued at $2.12 per share,57,971 shares were bought.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Taich Adam bought 45,851 shares, generating $91,725 in total proceeds.
Before that, Casdin Partners Master Fund, L bought 250,000 shares. Standard BioTools Inc shares valued at $546,750 were divested by the Director at a price of $2.19 per share. As a result of the transaction, Casdin Partners Master Fund, L now holds 54,025,821 shares, worth roughly $81.04 million.
TD Cowen initiated its Standard BioTools Inc [LAB] rating to a Buy in a research note published on April 16, 2024; the price target was $3.50. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in early April with a ‘”a Buy”‘ rating. KeyBanc Capital Markets began covering LAB with “an Overweight” recommendation on July 12, 2023.
Price Performance Review of LAB
On Monday, Standard BioTools Inc [NASDAQ:LAB] saw its stock fall -5.06% to $1.50. Over the last five days, the stock has lost -32.74%. Standard BioTools Inc shares have fallen nearly -32.13% since the year began. Nevertheless, the stocks have fallen -31.82% over the past one year. While a 52-week high of $3.04 was reached on 04/09/24, a 52-week low of $1.21 was recorded on 08/01/24. SMA at 50 days reached $1.9084, while 200 days put it at $2.2052.
Levels Of Support And Resistance For LAB Stock
The 24-hour chart illustrates a support level at 1.4600, which if violated will result in even more drops to 1.4200. On the upside, there is a resistance level at 1.5600. A further resistance level may holdings at 1.6200. The Relative Strength Index (RSI) on the 14-day chart is 32.50, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.3731, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 97.62%. Stochastics %K at 2.78% indicates the stock is a buying.
How much short interest is there in Standard BioTools Inc?
A steep rise in short interest was recorded in Standard BioTools Inc stocks on 2024-10-31, dropping by -1.75 million shares to a total of 19.54 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 21.29 million shares. There was a decline of -8.97%, which implies that there is a negative sentiment for the stock.
